Quick Answer
NANOVIRICIDES, INC. reported Total Assets of $8.82 million for the year ending 2025.
- NANOVIRICIDES, INC. showed a decrease of -31.2% in Total Assets from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $10.76 million | Q4 2011: $13.56 million | Q1 2012: $14.38 million | Q2 2012: $15.63 million | Q3 2012: $14.35 million | Q2 2013: $16.41 million | Q4 2013: $22.89 million | Q1 2014: $40.95 million | Q3 2014: $49.02 million | Q1 2015: $45.60 million | Q2 2015: $44.19 million | Q3 2015: $42.30 million | Q4 2015: $40.85 million | Q1 2016: $38.32 million | Q3 2016: $34.22 million | Q4 2016: $31.36 million | Q1 2017: $28.58 million | Q3 2017: $25.27 million | Q4 2017: $23.73 million | Q1 2018: $22.34 million | Q3 2018: $17.37 million | Q4 2018: $15.00 million | Q1 2019: $15.39 million | Q3 2019: $11.79 million | Q4 2019: $11.62 million | Q1 2020: $16.53 million | Q3 2020: $31.85 million | Q4 2020: $28.09 million | Q1 2021: $32.76 million | Q3 2021: $29.18 million | Q4 2021: $26.81 million | Q1 2022: $25.14 million | Q3 2022: $22.08 million | Q4 2022: $20.33 million | Q1 2023: $18.58 million | Q3 2023: $15.42 million | Q4 2023: $13.40 million | Q1 2024: $11.46 million | Q3 2024: $11.74 million | Q4 2024: $11.57 million | Q1 2025: $10.03 million | Q2 2025: $8.82 million | Q3 2025: $8.36 million | Q4 2025: $12.27 million.
- Over the full 12 years of available data (2014 to 2025), NANOVIRICIDES, INC.'s Total Assets has declined by 79.9%.
- Historical annual values: Fiscal year 2025: $8.82 million | Fiscal year 2024: $12.82 million | Fiscal year 2023: $16.90 million | Fiscal year 2022: $23.49 million | Fiscal year 2021: $30.26 million | Fiscal year 2020: $23.91 million | Fiscal year 2019: $13.45 million | Fiscal year 2018: $18.55 million | Fiscal year 2017: $27.00 million | Fiscal year 2016: $36.63 million | Fiscal year 2015: $44.19 million | Fiscal year 2014: $43.86 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: